BRAIN Biotech is a key player in the bio-based economy
BRAIN Biotech AG ranks among the technologically leading companies in Europe in the bioeconomy area, and operates in industrial biotechnology with its key technologies.
BRAIN Biotech identifies previously untapped high-performing enzymes, microbial producer organisms and natural compounds derived from complex biological systems to transform them into industrially usable applications.
Innovative solutions and products developed from this Toolbox of Nature are successfully deployed in the chemicals sector, as well as in the cosmetics and food manufacturing industries.
As part of its growth-oriented industrialization strategy, BRAIN Biotech AG (ISIN DE0005203947 / WKN 520394) has been the first bioeconomy company to be listed in the Prime Standard of the Frankfurt Stock Exchange since February 2016.
BRAIN Biotech AG – Elevator Pitch 2023
English version see below German version
-
Investor Relations Presentation
3M Financial Results Q1 2023/24
Investor Relations
Selected publications and financial events
Investor Relations service
You want to invest in BRAIN Biotech AG or have questions? We are here for you. Please get in touch with us.